These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30470475)

  • 1. Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes.
    Salvo F; Faillie JL
    Therapie; 2019 Apr; 74(2):255-260. PubMed ID: 30470475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.
    Acton EK; Willis AW; Hennessy S
    Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):9-18. PubMed ID: 36216785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of insulin initiation in diabetes care.
    Pogach LM
    CMAJ; 2009 Jun; 180(13):1287-8. PubMed ID: 19546448
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies.
    Willame C; Baril L; van den Bosch J; Ferreira GL; Williams R; Rosillon D; Cohet C
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1397-1406. PubMed ID: 27601179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies.
    Pye SR; Sheppard T; Joseph RM; Lunt M; Girard N; Haas JS; Bates DW; Buckeridge DL; van Staa TP; Tamblyn R; Dixon WG
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):781-788. PubMed ID: 29667263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulation study of instrumental variable approaches with an application to a study of the antidiabetic effect of bezafibrate.
    Cai B; Hennessy S; Flory JH; Sha D; Ten Have TR; Small DS
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():114-20. PubMed ID: 22552986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.
    Suissa S; Moodie EE; Dell'Aniello S
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):459-468. PubMed ID: 27610604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of oral antihyperglycemic drugs over a 7-year period (1998-2004) in a Hungarian population and adherence to drug therapy.
    Doró P; Benko R; Kosik E; Matuz M; Tóth K; Soós G
    Eur J Clin Pharmacol; 2005 Dec; 61(12):893-7. PubMed ID: 16328320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
    Montastruc JL; Benevent J; Montastruc F; Bagheri H; Despas F; Lapeyre-Mestre M; Sommet A
    Therapie; 2019 Apr; 74(2):169-174. PubMed ID: 30389102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes pharmacoepidemiology update 2014: safety versus efficacy.
    Singh S
    Curr Diab Rep; 2014 Dec; 14(12):563. PubMed ID: 25363547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using propensity scores subclassification to estimate effects of longitudinal treatments: an example using a new diabetes medication.
    Segal JB; Griswold M; Achy-Brou A; Herbert R; Bass EB; Dy SM; Millman AE; Wu AW; Frangakis CE
    Med Care; 2007 Oct; 45(10 Supl 2):S149-57. PubMed ID: 17909374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong.
    Lau GS; Chan JC; Chu PL; Tse DC; Critchely JA
    Ann Pharmacother; 1996 Mar; 30(3):232-7. PubMed ID: 8833556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.
    Hennessy S; Leonard CE; Gagne JJ; Flory JH; Han X; Brensinger CM; Bilker WB
    Clin Pharmacol Ther; 2016 Jan; 99(1):92-100. PubMed ID: 26479278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of health care databases for pharmacoepidemiology.
    Takahashi Y; Nishida Y; Asai S
    Eur J Clin Pharmacol; 2012 Feb; 68(2):123-9. PubMed ID: 21808989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
    Etminan M; Samii A
    Pharmacotherapy; 2004 Aug; 24(8):964-9. PubMed ID: 15338844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.